APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polio Vaccine

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

Selected research

Market Outlook & Growth Opportunities

Global Polio Vaccine Market Outlook and Growth Opportunities 2026

2 January 2026193 pages

Choose your research edition.

Industry ResearchPolio Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Polio Vaccine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Polio Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polio Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Polio Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.

Read the full market overview

This report provides an overview of the global Polio Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Polio Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Polio Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Polio Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Polio Vaccine Segment by Company

Sanofi

GSK

Bibcol

Serum Institute

Tiantan Biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Polio Vaccine Segment by Type

Inactivated Polio Vaccine (IPV)

Oral Polio Vaccine (OPV)

Polio Vaccine Segment by Application

Public

Private

Polio Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Polio Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Polio Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Polio Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Polio Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Polio Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Polio Vaccine industry.

Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Polio Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Polio Vaccine Industry Trends Table 2. Polio Vaccine Industry Drivers Table 3. Polio Vaccine Industry Opportunities and Challenges Table 4. Polio Vaccine Industry Restraints Table 5. Global Polio Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Polio Vaccine Revenue Share by Company (2021-2026) Table 7. Global Polio Vaccine Sales Volume by Company (M Doses) & (2021-2026) Table 8. Global Polio Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Polio Vaccine Average Price (USD/K Doses) of Company (2021-2026) Table 10. Global Polio Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Polio Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Polio Vaccine Company, Product Type & Application Table 13. Global Polio Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Inactivated Polio Vaccine (IPV) Table 18. Significant Companies of Oral Polio Vaccine (OPV) Table 19. Global Polio Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (M Doses) Table 20. Global Polio Vaccine Sales Volume by Type (2021-2026) & (M Doses) Table 21. Global Polio Vaccine Sales Volume by Type (2027-2032) & (M Doses) Table 22. Global Polio Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Polio Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Polio Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Polio Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Polio Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Polio Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Polio Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Public Table 30. Significant Companies of Private Table 31. Global Polio Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (M Doses) Table 32. Global Polio Vaccine Sales Volume by Application (2021-2026) & (M Doses) Table 33. Global Polio Vaccine Sales Volume by Application (2027-2032) & (M Doses) Table 34. Global Polio Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Polio Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Polio Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Polio Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Polio Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Polio Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Polio Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Polio Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 42. Global Polio Vaccine Sales by Region (2021-2026) & (M Doses) Table 43. Global Polio Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Polio Vaccine Sales by Region (2027-2032) & (M Doses) Table 45. Global Polio Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Polio Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Polio Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Polio Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Polio Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Polio Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Polio Vaccine Market Average Price (USD/K Doses) by Region (2021-2026) Table 52. Global Polio Vaccine Market Average Price (USD/K Doses) by Region (2027-2032) Table 53. Global Polio Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Table 54. Global Polio Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Polio Vaccine Sales by Country (2021-2026) & (M Doses) Table 56. Global Polio Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Polio Vaccine Sales by Country (2027-2032) & (M Doses) Table 58. Global Polio Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Polio Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Polio Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Polio Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Polio Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 66. Sanofi Polio Vaccine Product Portfolio Table 67. Sanofi Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 71. GSK Polio Vaccine Product Portfolio Table 72. GSK Recent Development Table 73. Bibcol Company Information Table 74. Bibcol Business Overview Table 75. Bibcol Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 76. Bibcol Polio Vaccine Product Portfolio Table 77. Bibcol Recent Development Table 78. Serum Institute Company Information Table 79. Serum Institute Business Overview Table 80. Serum Institute Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 81. Serum Institute Polio Vaccine Product Portfolio Table 82. Serum Institute Recent Development Table 83. Tiantan Biological Company Information Table 84. Tiantan Biological Business Overview Table 85. Tiantan Biological Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 86. Tiantan Biological Polio Vaccine Product Portfolio Table 87. Tiantan Biological Recent Development Table 88. IMBCA Company Information Table 89. IMBCA Business Overview Table 90. IMBCA Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 91. IMBCA Polio Vaccine Product Portfolio Table 92. IMBCA Recent Development Table 93. Panacea Biotec Ltd Company Information Table 94. Panacea Biotec Ltd Business Overview Table 95. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 96. Panacea Biotec Ltd Polio Vaccine Product Portfolio Table 97. Panacea Biotec Ltd Recent Development Table 98. Bio-Med Company Information Table 99. Bio-Med Business Overview Table 100. Bio-Med Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 101. Bio-Med Polio Vaccine Product Portfolio Table 102. Bio-Med Recent Development Table 103. Halfkin Bio-Pharmaceuticals Company Information Table 104. Halfkin Bio-Pharmaceuticals Business Overview Table 105. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 106. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio Table 107. Halfkin Bio-Pharmaceuticals Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Polio Vaccine Distributors List Table 111. Polio Vaccine Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Polio Vaccine Product Image Figure 2. Global Polio Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polio Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Polio Vaccine Sales (2021-2032) & (M Doses) Figure 5. Global Polio Vaccine Sales Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Polio Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Inactivated Polio Vaccine (IPV) Image Figure 10. Oral Polio Vaccine (OPV) Image Figure 11. Global Polio Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 12. Global Polio Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Polio Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Polio Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Polio Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Polio Vaccine Sales Value Share by Type (2021-2032) Figure 17. Public Image Figure 18. Private Image Figure 19. Global Polio Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 20. Global Polio Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Polio Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Polio Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Polio Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Polio Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Polio Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 26. Global Polio Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Polio Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Polio Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Polio Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Polio Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Polio Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Polio Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Polio Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Polio Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Polio Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Polio Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Polio Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Polio Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Polio Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Polio Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Polio Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Polio Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Polio Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Polio Vaccine (IPV)
  • Oral Polio Vaccine (OPV)
Applications
  • Public
  • Private
Companies covered
  • Sanofi
  • GSK
  • Bibcol
  • Serum Institute
  • Tiantan Biological
  • IMBCA
  • Panacea Biotec Ltd
  • Bio-Med
  • Halfkin Bio-Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Polio Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Polio Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Polio Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Polio Vaccine Market Dynamics
  1. 2.1 Polio Vaccine Industry Trends
  2. 2.2 Polio Vaccine Industry Drivers
  3. 2.3 Polio Vaccine Industry Opportunities and Challenges
  4. 2.4 Polio Vaccine Industry Restraints
3 Polio Vaccine Market by Company
  1. 3.1 Global Polio Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Polio Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Polio Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Polio Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Polio Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Polio Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Polio Vaccine Company Product Type and Application
  8. 3.8 Global Polio Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Polio Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Polio Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Polio Vaccine Market by Type
  1. 4.1 Polio Vaccine Type Introduction
  2. 4.1.1 Inactivated Polio Vaccine (IPV)
  3. 4.1.2 Oral Polio Vaccine (OPV)
  4. 4.2 Global Polio Vaccine Sales Volume by Type
  5. 4.2.1 Global Polio Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Polio Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Polio Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Polio Vaccine Sales Value by Type
  9. 4.3.1 Global Polio Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Polio Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Polio Vaccine Sales Value Share by Type (2021-2032)
5 Polio Vaccine Market by Application
  1. 5.1 Polio Vaccine Application Introduction
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Polio Vaccine Sales Volume by Application
  5. 5.2.1 Global Polio Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Polio Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Polio Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Polio Vaccine Sales Value by Application
  9. 5.3.1 Global Polio Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Polio Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Polio Vaccine Sales Value Share by Application (2021-2032)
6 Polio Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Polio Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Polio Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Polio Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Polio Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Polio Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Polio Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Polio Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Polio Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Polio Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Polio Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Polio Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Polio Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Polio Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Polio Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Polio Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Polio Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Polio Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Polio Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Polio Vaccine Sales Value Share by Country, 2025 VS 2032
7 Polio Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Polio Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Polio Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Polio Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Polio Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Polio Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Polio Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Polio Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Polio Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Polio Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Polio Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Polio Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Polio Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Polio Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Polio Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Polio Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Polio Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Polio Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Polio Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Polio Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Polio Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Polio Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Polio Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Polio Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Polio Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Polio Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Polio Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Polio Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Polio Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Polio Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Polio Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Polio Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Polio Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Polio Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Polio Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Polio Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Polio Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Polio Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Polio Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Polio Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Polio Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Polio Vaccine Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Polio Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GSK Polio Vaccine Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Bibcol
  14. 8.3.1 Bibcol Company Information
  15. 8.3.2 Bibcol Business Overview
  16. 8.3.3 Bibcol Polio Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bibcol Polio Vaccine Product Portfolio
  18. 8.3.5 Bibcol Recent Developments
  19. 8.4 Serum Institute
  20. 8.4.1 Serum Institute Company Information
  21. 8.4.2 Serum Institute Business Overview
  22. 8.4.3 Serum Institute Polio Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Serum Institute Polio Vaccine Product Portfolio
  24. 8.4.5 Serum Institute Recent Developments
  25. 8.5 Tiantan Biological
  26. 8.5.1 Tiantan Biological Company Information
  27. 8.5.2 Tiantan Biological Business Overview
  28. 8.5.3 Tiantan Biological Polio Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Tiantan Biological Polio Vaccine Product Portfolio
  30. 8.5.5 Tiantan Biological Recent Developments
  31. 8.6 IMBCA
  32. 8.6.1 IMBCA Company Information
  33. 8.6.2 IMBCA Business Overview
  34. 8.6.3 IMBCA Polio Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 IMBCA Polio Vaccine Product Portfolio
  36. 8.6.5 IMBCA Recent Developments
  37. 8.7 Panacea Biotec Ltd
  38. 8.7.1 Panacea Biotec Ltd Company Information
  39. 8.7.2 Panacea Biotec Ltd Business Overview
  40. 8.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
  42. 8.7.5 Panacea Biotec Ltd Recent Developments
  43. 8.8 Bio-Med
  44. 8.8.1 Bio-Med Company Information
  45. 8.8.2 Bio-Med Business Overview
  46. 8.8.3 Bio-Med Polio Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bio-Med Polio Vaccine Product Portfolio
  48. 8.8.5 Bio-Med Recent Developments
  49. 8.9 Halfkin Bio-Pharmaceuticals
  50. 8.9.1 Halfkin Bio-Pharmaceuticals Company Information
  51. 8.9.2 Halfkin Bio-Pharmaceuticals Business Overview
  52. 8.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
  54. 8.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Polio Vaccine Value Chain Analysis
  2. 9.1.1 Polio Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Polio Vaccine Sales Mode & Process
  6. 9.2 Polio Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Polio Vaccine Distributors
  9. 9.2.3 Polio Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst